cardinal health glp-1 receptor agonist weight management diabetes treatments Efficacy and Safety of Glucagon-Like Indications for GLP-1/GIP RA Summary
Description
This gives it a logistical advantage over injectable GLP-1 formulations a potentially important consideration for expanding access in low- and middle-income countries, where cold chain infrastructure is unreliable
Knudsen LB, Lau J
And remember: you cannot double-dip
Suspected adverse reactions should be reported via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
Pharmacokinetics and safety profiles of beinaglutide injection, a Recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial
